The ASPIRE trial employs a randomized, controlled design, which is the gold standard in clinical research. Participants are randomly assigned to receive either the experimental treatment regimen or the standard of care. This design helps to eliminate bias and ensures that any observed differences in outcomes can be attributed to the treatment itself. The trial is conducted in multiple phases, with each phase focusing on different aspects of treatment effectiveness and safety.
